Agios

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agios and other ETFs, options, and stocks.

About AGIO

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. 

CEO
Brian M. Goff
CEOBrian M. Goff
Employees
540
Employees540
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
540
Employees540

AGIO Key Statistics

Market cap
2.24B
Market cap2.24B
Price-Earnings ratio
-5.12
Price-Earnings ratio-5.12
Dividend yield
Dividend yield
Average volume
1.35M
Average volume1.35M
High today
$38.38
High today$38.38
Low today
$36.35
Low today$36.35
Open price
$37.30
Open price$37.30
Volume
286.26K
Volume286.26K
52 Week high
$46.00
52 Week high$46.00
52 Week low
$22.24
52 Week low$22.24

Stock Snapshot

Agios(AGIO) stock is priced at $37.72, giving the company a market capitalization of 2.24B. It carries a P/E multiple of -5.12.

On 2026-07-01, Agios(AGIO) stock moved within a range of $36.35 to $38.38. With shares now at $37.72, the stock is trading +3.8% above its intraday low and -1.7% below the session's peak.

Trading volume for Agios(AGIO) stock has reached 286.26K, versus its average volume of 1.35M.

Over the past 52 weeks, Agios(AGIO) stock has traded between a high of $46.00 and a low of $22.24.

Over the past 52 weeks, Agios(AGIO) stock has traded between a high of $46.00 and a low of $22.24.

AGIO News

Simply Wall St 2h
How Agios Pharmaceuticals' Shift Into Russell Growth Indices Will Impact Agios Pharmaceuticals Investors - simplywall.st

...

How Agios Pharmaceuticals' Shift Into Russell Growth Indices Will Impact Agios Pharmaceuticals Investors - simplywall.st
Simply Wall St 6d
Agios Pharmaceuticals Could Be 11% Undervalued Following Its Rare Disease Growth Narrative

Advertisement Short term stock performance in focus Agios Pharmaceuticals (AGIO) has drawn fresh attention after a recent move in its share price, with the st...

Agios Pharmaceuticals Could Be 11% Undervalued Following Its Rare Disease Growth Narrative

Analyst ratings

70%

of 10 ratings
Buy
70%
Hold
30%
Sell
0%

People also own

Based on the portfolios of people who own AGIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.